Skip to content

EFFECT OF YOGA ON PATIENTS WITH ESSENTIAL TREMOR

EFFECT OF INTEGRATED YOGA MODULE ON THE PATIENTS WITH ESSENTIAL TREMOR

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/06/053982
Enrollment
60
Registered
2023-06-16
Start date
Unknown
Completion date
Unknown
Last updated
2023-06-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G250- Essential tremor

Interventions

Intervention1: Standard Drug Therapy and Yoga Module: This study will evaluate the â??EFFECT OF INTEGRATED YOGA MODULE ON PATIENTS WITH ESSENTIAL TREMOR.â?? The 60 (sixty) patients with Essential Tr

Sponsors

Department of Swasthavritta and Yoga Faculty of Ayurveda Institute of Medical Sciences
Lead Sponsor
Department of Neurology Faculty of Medicine Institute of Medical Sciences BHU
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: 1 Male and female patients fulfilling diagnostic criteria of Essential Tremor (According to Task Force on Tremor of the International Parkinson and Movement Disorder Society- 2018) 2 Patients with ET of age > 18 years to 65 years 3 Patients willing to participate, with their written consent. 4 Patients able to join Yoga Session in online/offline mode. 5 Patients able to follow instructions during Yoga Session.

Exclusion criteria

Exclusion criteria: 1 Patients with Essential Tremor of age 65 years. 2 Patients having any atypical movement disorder (e.g., Essential Tremor in combination with Parkinsonâ??s Disease). 3 Patients with known causes of enhanced physiological tremor viz, current or recent exposure to tremorogenic drugs or presence of drug withdrawal state. 4 Patients with past history of Head Injury, Stroke, Brain or Abdominal Surgery and any abnormal Brain MRI. 5 Patients suffering from any severe disease viz, Chronic Liver disease, Chronic Renal disease, Chronic Musculo-skeletal disorders, Coronary Artery Disease, Cancer, Psychogenic Tremor etc. 6 Patients consuming Alcohol or Anti-Psychotic drugs. 7 Patients unable to complete the questionnaires. 8 Pregnant Women.

Design outcomes

Primary

MeasureTime frame
Essential Tremor severity scale (TETRAs) Essential Tremor balance scale (FULLERTON ADVANCED BALANCE SCALE) Anxiety and Depression Scale (The Hospital Anxiety and Depression Scale) Quality of Life in Essential Tremor Questionnaire (QUEST)Timepoint: The primary outcome of both groups will be assessed at 0 month (baseline), after 1 month (first follow-up), after 2 months (second follow-up), and after 3 months (post-intervention follow-up).

Secondary

MeasureTime frame
CBC RBS LFT RFT Lipid ProfileTimepoint: The secondary outcome of both groups will be assessed at 0 month (baseline) and after two months (second follow-up).

Countries

India

Contacts

Public ContactMrityunjay Patidar

Banaras Hindu University

nsneeru@bhu.ac.in9935655129

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026